DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Hogan Ii RB, Hogan Iii RB, Cannon T. et al.
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary
symptoms in COVID-19 patients.
PulmPharmacolTher 2020;
63: 101942
DOI: 10.1016/j.pupt.2020.101942.
We do not assume any responsibility for the contents of the web pages of other providers.